Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -0.45%624.73M | -6.88%380.6M | -17.25%172.67M | 10.15%846.13M | 10.15%627.56M | 12.37%408.71M | 18.55%208.66M | -7.58%768.15M | -1.02%569.73M | 0.02%363.72M |
| Refunds of taxes and levies | -10.27%9.87M | -37.31%6.56M | -57.21%2.24M | 185.44%11.99M | 125.73%10.99M | 280.19%10.46M | 1,445.94%5.24M | 40.74%4.2M | 14.06%4.87M | -0.02%2.75M |
| Cash received relating to other operating activities | -43.60%7.98M | -26.59%6.47M | -15.99%4.27M | 10.33%28.24M | -48.15%14.14M | -43.27%8.82M | 12.61%5.08M | 99.82%25.6M | 166.08%27.28M | 206.19%15.54M |
| Cash inflows from operating activities | -1.55%642.57M | -8.03%393.63M | -18.17%179.18M | 11.08%886.37M | 8.44%652.7M | 12.03%427.98M | 21.08%218.98M | -5.79%797.96M | 1.99%601.89M | 2.84%382.01M |
| Goods services cash paid | 1.12%426.11M | -13.18%252.36M | 37.71%159.23M | 40.85%594.32M | 34.36%421.4M | 62.20%290.67M | 48.44%115.62M | -4.36%421.96M | -0.03%313.63M | -17.50%179.2M |
| Staff behalf paid | 11.04%163.15M | 16.62%122.29M | 15.12%70.79M | 13.54%190.96M | 18.02%146.93M | 29.48%104.86M | 20.07%61.5M | 20.66%168.18M | 10.68%124.5M | -5.36%80.99M |
| All taxes paid | -6.26%32.78M | -10.18%23.5M | -12.11%6.42M | -6.74%48.57M | -14.44%34.97M | -6.69%26.17M | -48.78%7.3M | 14.75%52.07M | 31.44%40.88M | 70.26%28.05M |
| Cash paid relating to other operating activities | 1.27%49.74M | -6.07%31.04M | -4.67%16.58M | 10.39%78.59M | -14.31%49.12M | -22.33%33.05M | 15.10%17.39M | 25.74%71.19M | 95.50%57.32M | 162.53%42.55M |
| Cash outflows from operating activities | 2.97%671.78M | -5.62%429.2M | 25.37%253.02M | 27.90%912.44M | 21.65%652.41M | 37.48%454.75M | 27.35%201.81M | 4.51%713.41M | 10.21%536.32M | -1.40%330.79M |
| Net cash flows from operating activities | -10,232.26%-29.2M | -32.88%-35.57M | -530.04%-73.83M | -130.84%-26.07M | -99.56%288.23K | -152.26%-26.77M | -23.31%17.17M | -48.57%84.55M | -36.65%65.56M | 42.32%51.23M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 17.62%606.76M | 41.14%434.51M | -44.67%147.41M | -47.53%798.34M | -52.22%515.86M | -64.13%307.86M | -65.11%266.4M | -1.08%1.52B | -31.28%1.08B | -16.24%858.16M |
| Cash received from returns on investments | 407.41%18.6M | 189.52%9.03M | -73.23%749.62K | -80.37%1.32M | -66.98%3.67M | -69.09%3.12M | -54.96%2.8M | -63.30%6.72M | -48.63%11.1M | -14.70%10.09M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 97.70%51.5K | 930.00%51.5K | ---- | -93.78%315.2K | -60.70%26.05K | -59.32%5K | ---- | 818.52%5.07M | --66.29K | --12.29K |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash received relating to other investing activities | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash inflows from investing activities | 20.38%625.42M | 42.64%443.58M | -44.96%148.15M | -47.83%799.97M | -52.37%519.55M | -64.18%310.98M | -65.03%269.2M | -1.52%1.53B | -31.51%1.09B | -16.22%868.26M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -18.10%24.74M | -54.32%12.71M | -66.51%8.52M | -55.96%25.97M | 87.16%30.21M | 306.14%27.82M | 1,162.55%25.43M | 93.85%58.98M | -26.40%16.14M | -53.93%6.85M |
| Cash paid to acquire investments | -27.95%403.44M | 21.01%378.24M | -34.24%142.43M | -46.43%756.87M | -9.98%559.92M | 0.83%312.58M | -13.19%216.58M | -5.99%1.41B | -62.23%622M | -68.43%310M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | --0 | ---- | ---- | ---- | 23.35%71.51M | --67.22M | ---- |
| Cash paid relating to other investing activities | 125.91%39.62M | 125.45%39.54M | 125.45%39.54M | --0 | --17.54M | --17.54M | 208.97%17.54M | --0 | ---- | ---- |
| Cash outflows from investing activities | -23.02%467.81M | 20.27%430.49M | -26.61%190.49M | -49.28%782.85M | -13.85%607.67M | 12.97%357.94M | 0.92%259.55M | -3.01%1.54B | -58.67%705.36M | -69.38%316.85M |
| Net cash flows from investing activities | 278.86%157.61M | 127.88%13.09M | -538.51%-42.33M | 270.21%17.13M | -122.86%-88.12M | -108.52%-46.96M | -98.12%9.65M | 70.69%-10.06M | 437.88%385.47M | 34,603.94%551.41M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --24.56M | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash from borrowing | 10.68%265.5M | 96.07%229.6M | 5,266.67%80.5M | 23,889.00%239.89M | 23,889.00%239.89M | 11,610.00%117.1M | 50.00%1.5M | -95.00%1M | -95.00%1M | -90.00%1M |
| Cash received relating to other financing activities | --19.85M | ---- | ---- | 389.65%29.65M | ---- | ---- | ---- | 2,027.60%6.06M | --24.56M | --24.56M |
| Cash inflows from financing activities | 18.95%285.35M | 96.07%229.6M | 5,266.67%80.5M | 752.53%269.54M | 838.50%239.89M | 358.12%117.1M | 50.00%1.5M | 55.86%31.62M | 27.81%25.56M | 155.61%25.56M |
| Borrowing repayment | 1,002.66%252.4M | --122.4M | --5.4M | 704.34%127.89M | 43.96%22.89M | ---- | ---- | -60.25%15.9M | -47.00%15.9M | -63.33%11M |
| Dividend interest payment | 4,999.85%64.95M | 64,710.33%64.27M | 77,387.43%561.78K | -96.27%2.42M | -98.03%1.27M | -99.85%99.17K | -98.72%725 | 0.64%64.73M | 0.62%64.73M | 0.81%64.71M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash payments relating to other financing activities | -93.26%7.17M | -93.89%6.5M | -94.33%5.71M | 134.91%108.15M | 715.85%106.39M | 264,873.75%106.39M | --100.7M | 5,343.15%46.04M | 72,986.82%13.04M | 125.03%40.15K |
| Cash outflows from financing activities | 148.58%324.53M | 81.41%193.18M | -88.41%11.67M | 88.26%238.46M | 39.38%130.55M | 40.57%106.49M | 1,891.52%100.7M | 20.45%126.67M | -0.72%93.67M | -19.59%75.75M |
| Net cash flows from financing activities | -135.83%-39.18M | 243.19%36.42M | 169.39%68.83M | 132.70%31.08M | 260.54%109.34M | 121.15%10.61M | -2,345.49%-99.2M | -11.99%-95.05M | 8.39%-68.11M | 40.40%-50.19M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -713.31%-692.99K | -122.78%-194.22K | -102.78%-13.42K | 255.72%1.16M | 180.95%112.99K | 1,231.38%852.59K | 180.63%483.22K | -73.25%327.39K | -105.69%-139.58K | -104.29%-75.36K |
| Net increase in cash and cash equivalents | 309.52%88.54M | 122.09%13.75M | 34.14%-47.35M | 215.11%23.3M | -94.35%21.62M | -111.27%-62.26M | -113.56%-71.89M | -143.63%-20.24M | 564.10%382.79M | 1,331.13%552.37M |
| Add:Begin period cash and cash equivalents | 14.69%181.88M | 14.69%181.88M | 14.69%181.88M | -11.32%158.58M | -11.32%158.58M | -11.32%158.58M | 4.34%158.58M | 35.04%178.82M | 35.04%178.82M | 35.04%178.82M |
| End period cash equivalent | 50.06%270.42M | 103.11%195.63M | 55.19%134.53M | 14.69%181.88M | -67.91%180.2M | -86.83%96.32M | -87.30%86.69M | -11.32%158.58M | 1,024.44%561.61M | 735.09%731.19M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.